LAUREN DAGGETT: Open Payments
NPI 1801525621 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 45 payments from 12 companies in 2025. Trend: 2023 $424 · 2024 $1,567 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $161 |
| PFIZER INC. | 12 | $144 |
| ABIOMED | 5 | $133 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $98 |
| Merck Sharp & Dohme LLC | 4 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| SCPHARMACEUTICALS INC. | 2 | $48 |
| BridgeBio Pharma, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $20 |
Products named: LEQVIO, ELIQUIS, JARDIANCE, VERQUVO, Kerendia, FUROSCIX, Attruby, Repatha.
Industry payments across CA — which companies pay providers there.
